This article evaluates the major challenges in choosing therapeutics to prevent congenital ZIKV disease and conducting clinical trials of these treatments, with a focus on preventing congenital central nervous system malformations. This article was first published in Annals of Internal Medicine.

24th March 2017 • 0 comments

Outbreak: Lessons From Ebola

by ERGO Editorial Team

  Charvy Narain describes how Oxford medics found themselves on the front line

9th February 2016 • 0 comments